MiLOC Group Ltd
The group will be principally engaged in (i) the research and development of TCM specifically for pandemic diseases; (ii) the sale and distribution of TCM; and (iii) the development and operation of a network of high quality modern TCM clinics and hospitals in China, Hong Kong and Macau.
|Symbol||Ccy Code||Bid||Ask||Share Price (Mid)||Previous Close||Volume||Last Traded|
MiFID II compliant pre- and post-trade transaction data is available here. The data is delayed by at least 15 minutes and will be refreshed every 15 minutes. Publication of trades in equity securities that are large in scale compared to normal market size and illiquid non-equity securities may be delayed if the trade is eligible for deferred publication in accordance with the trading rules of Aquis Stock Exchange and MiFIR. Further details as to when the publication of a trade may be deferred are set out in the trading rules which are available here.